EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Concurrent chemoradiotherapy plus anlotinib vs. concurrent chemoradiotherapy alone in locally advanced nasopharyngeal carcinoma: An interim analysis of a multicenter randomized controlled trial

Kequan Chen, Guoding Xu, Yong Liang, Ping Liang, Weiwei Gao, Zhou Li, Weichao Liang, Zheng Tao, Jiaxin Chen, Xiaohua Hu, Yaocan Xu

Oncology Letters · 27.07.2023 · 26 (3)

DOI: 10.3892/ol.2023.13978 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Oncology Letters, online erschienen am 27.07.2023. Verfasst von Kequan Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Guiping People's Hospital, Guiping, Guangxi Zhuang Autonomous Region 537200, P.R. China. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

anlotinibcisplatinconcurrent chemotherapylocoregionally advancednasopharyngeal carcinoma

Autor:innen und Institutionen

  • Department of Oncology, Guiping People's Hospital, Guiping, Guangxi Zhuang Autonomous Region 537200, P.R. China.
  • Department of Oncology, The First People's Hospital of Nanning, The Fifth Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530022, P.R. China.
  • Department of Oncology and Radiotherapy, Guangxi Academy of Medical Sciences, The People's Hospital of Guangxi Zhuang, Nanning, Guangxi Zhuang Autonomous Region 530021, P.R. China.
  • Department of Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530021, P.R. China.

Zitieren

APA

Chen, K., Xu, G., Liang, Y., Liang, P., Gao, W., Li, Z., Liang, W., Tao, Z., Chen, J., Hu, X., & Xu, Y. (2023). Concurrent chemoradiotherapy plus anlotinib vs. concurrent chemoradiotherapy alone in locally advanced nasopharyngeal carcinoma: An interim analysis of a multicenter randomized controlled trial. Oncology Letters, 26(3). https://doi.org/10.3892/ol.2023.13978

Vancouver

Chen K, Xu G, Liang Y, Liang P, Gao W, Li Z, et al. Concurrent chemoradiotherapy plus anlotinib vs. concurrent chemoradiotherapy alone in locally advanced nasopharyngeal carcinoma: An interim analysis of a multicenter randomized controlled trial. Oncology Letters. 2023;26(3). doi:10.3892/ol.2023.13978

BibTeX
@article{Chen2023,
  author = {Chen, Kequan and Xu, Guoding and Liang, Yong and Liang, Ping and Gao, Weiwei and Li, Zhou and Liang, Weichao and Tao, Zheng and Chen, Jiaxin and Hu, Xiaohua and Xu, Yaocan},
  title = {Concurrent chemoradiotherapy plus anlotinib vs. concurrent chemoradiotherapy alone in locally advanced nasopharyngeal carcinoma: An interim analysis of a multicenter randomized controlled trial},
  journal = {Oncology Letters},
  year = {2023},
  volume = {26},
  number = {3},
  doi = {10.3892/ol.2023.13978}
}
Kostenlos starten →